Omnicell, Inc. (OMCL)

Market Cap	1.37B
Revenue (ttm)	1.10B
Net Income (ttm)	-21.05M
Shares Out	45.92M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	20.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	423,543
Open	30.83
Previous Close	30.28
Day's Range	29.45 - 31.40
52-Week Range	25.69 - 77.14
Beta	0.77
Analysts	Buy
Price Target	43.25 (+44.79%)
Earnings Date	May 2, 2024

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing syst...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,650
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL

Analyst Forecast

According to 6 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price forecast is $43.25, which is an increase of 44.79% from the latest price.

Price Target

$43.25

(44.79% upside)

Analyst Consensus: Buy